137 related articles for article (PubMed ID: 16184606)
1. Adenosine A2A receptor dysfunction correlates with age at onset anticipation in blood platelets of subjects with Huntington's disease.
Maglione V; Giallonardo P; Cannella M; Martino T; Frati L; Squitieri F
Am J Med Genet B Neuropsychiatr Genet; 2005 Nov; 139B(1):101-5. PubMed ID: 16184606
[TBL] [Abstract][Full Text] [Related]
2. The platelet maximum number of A2A-receptor binding sites (Bmax) linearly correlates with age at onset and CAG repeat expansion in Huntington's disease patients with predominant chorea.
Maglione V; Cannella M; Martino T; De Blasi A; Frati L; Squitieri F
Neurosci Lett; 2006 Jan; 393(1):27-30. PubMed ID: 16221531
[TBL] [Abstract][Full Text] [Related]
3. A genetic variation in the ADORA2A gene modifies age at onset in Huntington's disease.
Dhaenens CM; Burnouf S; Simonin C; Van Brussel E; Duhamel A; Defebvre L; Duru C; Vuillaume I; Cazeneuve C; Charles P; Maison P; Debruxelles S; Verny C; Gervais H; Azulay JP; Tranchant C; Bachoud-Levi AC; Dürr A; Buée L; Krystkowiak P; Sablonnière B; Blum D;
Neurobiol Dis; 2009 Sep; 35(3):474-6. PubMed ID: 19591938
[TBL] [Abstract][Full Text] [Related]
4. Aberrant A2A receptor function in peripheral blood cells in Huntington's disease.
Varani K; Abbracchio MP; Cannella M; Cislaghi G; Giallonardo P; Mariotti C; Cattabriga E; Cattabeni F; Borea PA; Squitieri F; Cattaneo E
FASEB J; 2003 Nov; 17(14):2148-50. PubMed ID: 12958155
[TBL] [Abstract][Full Text] [Related]
5. Anticipation and instability of IT-15 (CAG)n repeats in parent-offspring pairs with Huntington disease.
Ranen NG; Stine OC; Abbott MH; Sherr M; Codori AM; Franz ML; Chao NI; Chung AS; Pleasant N; Callahan C
Am J Hum Genet; 1995 Sep; 57(3):593-602. PubMed ID: 7668287
[TBL] [Abstract][Full Text] [Related]
6. [Juvenile form of Huntington's disease--diagnostic problems].
Hoffman-Zacharska D; Zdzienicka E; Mierzewska H; Habib N; Kulczycki J; Zaremba J
Med Wieku Rozwoj; 1999; 3(1):123-32. PubMed ID: 10910644
[TBL] [Abstract][Full Text] [Related]
7. A critical evaluation of adenosine A2A receptors as potentially "druggable" targets in Huntington's disease.
Popoli P; Blum D; Domenici MR; Burnouf S; Chern Y
Curr Pharm Des; 2008; 14(15):1500-11. PubMed ID: 18537673
[TBL] [Abstract][Full Text] [Related]
8. Anticipation in families with Hodgkin's and non-Hodgkin's lymphoma in their pedigree.
Alexandrescu DT; Garino A; Brown-Balem KA; Wiernik PH
Leuk Lymphoma; 2006 Oct; 47(10):2115-27. PubMed ID: 17071485
[TBL] [Abstract][Full Text] [Related]
9. The Impact of Family History on the Clinical Features of Huntington's Disease.
Kringlen G; Kinsley L; Aufox S; Rouleau G; Bega D
J Huntingtons Dis; 2017; 6(4):327-335. PubMed ID: 28984613
[TBL] [Abstract][Full Text] [Related]
10. Instability of CAG repeats in Huntington's disease: relation to parental transmission and age of onset.
Trottier Y; Biancalana V; Mandel JL
J Med Genet; 1994 May; 31(5):377-82. PubMed ID: 8064815
[TBL] [Abstract][Full Text] [Related]
11. Anticipation is not associated with CAG repeat expansion in parent-offspring pairs of patients affected with schizophrenia.
Martorell L; Pujana MA; Valero J; Joven J; Volpini V; Labad A; Estivill X; Vilella E
Am J Med Genet; 1999 Feb; 88(1):50-6. PubMed ID: 10050967
[TBL] [Abstract][Full Text] [Related]
12. [Clinical characteristics of Huntington disease in two pedigrees and analysis of expanded CAG trinucleotide repeat].
Cao GN; Bao XH; Lu HM; Zhang JJ; Ma YN; Gu WH; Xiong H; Qin J; Wu XR
Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):163-7. PubMed ID: 21503105
[TBL] [Abstract][Full Text] [Related]
13. Family and molecular data for a fine analysis of age at onset in Huntington disease.
Squitieri F; Sabbadini G; Mandich P; Gellera C; Di Maria E; Bellone E; Castellotti B; Nargi E; de Grazia U; Frontali M; Novelletto A
Am J Med Genet; 2000 Dec; 95(4):366-73. PubMed ID: 11186892
[TBL] [Abstract][Full Text] [Related]
14. [Clinical and genetic study of juvenile form of Huntington's disease].
Zdzienicka E; Rakowicz M; Mierzewska H; Hoffman-Zacharska D; Jakubowska T; Poniatowska R; Sułek A; Waliniowska E; Zalewska U; Kulczycki J; Zaremba J
Neurol Neurochir Pol; 2002; 36(2):245-58. PubMed ID: 12046502
[TBL] [Abstract][Full Text] [Related]
15. An intergenerational contraction of a fully penetrant Huntington disease allele to a reduced penetrance allele: interpretation of results and significance for risk assessment and genetic counseling.
Nahhas F; Garbern J; Feely S; Feldman GL
Am J Med Genet A; 2009 Feb; 149A(4):732-6. PubMed ID: 19267413
[TBL] [Abstract][Full Text] [Related]
16. Association between caffeine intake and age at onset in Huntington's disease.
Simonin C; Duru C; Salleron J; Hincker P; Charles P; Delval A; Youssov K; Burnouf S; Azulay JP; Verny C; Scherer C; Tranchant C; Goizet C; Debruxelles S; Defebvre L; Sablonnière B; Romon-Rousseaux M; Buée L; Destée A; Godefroy O; Dürr A; Landwehrmeyer B; ; Bachoud-Levi AC; Richard F; Blum D; Krystkowiak P;
Neurobiol Dis; 2013 Oct; 58():179-82. PubMed ID: 23732677
[TBL] [Abstract][Full Text] [Related]
17. Progressive Polyglutamine Repeat Expansion in Peripheral Blood Cells and Sperm of Transgenic Huntington's Disease Monkeys.
Clever F; Cho IK; Yang J; Chan AWS
J Huntingtons Dis; 2019; 8(4):443-448. PubMed ID: 31561381
[TBL] [Abstract][Full Text] [Related]
18. Reduced Cancer Incidence in Huntington's Disease: Analysis in the Registry Study.
McNulty P; Pilcher R; Ramesh R; Necuiniate R; Hughes A; Farewell D; Holmans P; Jones L;
J Huntingtons Dis; 2018; 7(3):209-222. PubMed ID: 30103338
[TBL] [Abstract][Full Text] [Related]
19. Venezuelan kindreds reveal that genetic and environmental factors modulate Huntington's disease age of onset.
Wexler NS; Lorimer J; Porter J; Gomez F; Moskowitz C; Shackell E; Marder K; Penchaszadeh G; Roberts SA; Gayán J; Brocklebank D; Cherny SS; Cardon LR; Gray J; Dlouhy SR; Wiktorski S; Hodes ME; Conneally PM; Penney JB; Gusella J; Cha JH; Irizarry M; Rosas D; Hersch S; Hollingsworth Z; MacDonald M; Young AB; Andresen JM; Housman DE; De Young MM; Bonilla E; Stillings T; Negrette A; Snodgrass SR; Martinez-Jaurrieta MD; Ramos-Arroyo MA; Bickham J; Ramos JS; Marshall F; Shoulson I; Rey GJ; Feigin A; Arnheim N; Acevedo-Cruz A; Acosta L; Alvir J; Fischbeck K; Thompson LM; Young A; Dure L; O'Brien CJ; Paulsen J; Brickman A; Krch D; Peery S; Hogarth P; Higgins DS; Landwehrmeyer B;
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3498-503. PubMed ID: 14993615
[TBL] [Abstract][Full Text] [Related]
20. The A2A adenosine receptor rescues the urea cycle deficiency of Huntington's disease by enhancing the activity of the ubiquitin-proteasome system.
Chiang MC; Chen HM; Lai HL; Chen HW; Chou SY; Chen CM; Tsai FJ; Chern Y
Hum Mol Genet; 2009 Aug; 18(16):2929-42. PubMed ID: 19443488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
